NervGen Pharma Corp. (TSXV: NGEN)

NervGen Pharma Statistics

Total Valuation

NervGen Pharma has a market cap or net worth of CAD 201.08 million. The enterprise value is 180.20 million.

Market Cap	201.08M
Enterprise Value	180.20M

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

NervGen Pharma has 70.31 million shares outstanding. The number of shares has increased by 9.52% in one year.

Current Share Class	n/a
Shares Outstanding	70.31M
Shares Change (YoY)	+9.52%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	4.16%
Float	58.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	21.87
P/TBV Ratio	23.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.01.

Current Ratio	1.66
Quick Ratio	1.59
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -336.09% and return on invested capital (ROIC) is -196.47%.

Return on Equity (ROE)	-336.09%
Return on Assets (ROA)	-74.07%
Return on Invested Capital (ROIC)	-196.47%
Return on Capital Employed (ROCE)	-249.70%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.39
52-Week Price Change	n/a
50-Day Moving Average	2.86
200-Day Moving Average	2.59
Relative Strength Index (RSI)	47.63
Average Volume (20 Days)	34,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.00M
Pretax Income	-24.01M
Net Income	-24.01M
EBITDA	-23.01M
EBIT	-23.00M
Earnings Per Share (EPS)	-0.37

Balance Sheet

The company has 21.01 million in cash and 129,016 in debt, giving a net cash position of 20.88 million or 0.30 per share.

Cash & Cash Equivalents	21.01M
Total Debt	129,016
Net Cash	20.88M
Net Cash Per Share	0.30
Equity (Book Value)	9.18M
Book Value Per Share	0.13
Working Capital	8.70M

Cash Flow

Operating Cash Flow	-16.27M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NervGen Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.52%
Shareholder Yield	-9.52%
Earnings Yield	-11.94%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a